Study to Evaluate the Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)

Distal Subungual Onychomycosis Clinical Trial

Official title:
A Multi-centre, Randomized, Two-armed, Parallel Group and Evaluator-blinded Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)

Status Completed

Clinical Trial Summary

The primary objective of this study is to evaluate the efficacy of topical MOB015B in patients with mild to moderate distal subungual onychomycosis (DSO).

The secondary objective is to evaluate the safety of topical MOB015B in patients with mild to moderate DSO.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02866032
Study type	Interventional
Source	Moberg Pharma AB
Contact
Status	Completed
Phase	Phase 3
Start date	September 2016
Completion date	June 10, 2020

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01093118` - A Study to Evaluate TMI-358 in the Treatment of Distal Subungual Onychomycosis	Phase 2
Completed	`NCT02859519` - A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)	Phase 3
Completed	`NCT04188574` - A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail	Phase 2
Completed	`NCT01814020` - An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)	Phase 2